Inmunodeficiencias primarias. Enfoque y tratamiento iniciales

1997, Clin Exp Immunol, 109, 1 Smith, 1996, The immunocompromised host, Pediatr Rev, 17, 435, 10.1542/pir.17-12-435 Puck, 1997, Primary immunodeficiency diseases, Jama, 278, 1835, 10.1001/jama.1997.03550220041007 Rosen, 1995, The primary immunodeficiencies, N Engl J Med, 333, 431, 10.1056/NEJM199508173330707 Buckley, 2000, Primary immunodeficiency diseases due to defects in lymphocytes, N Engl J Med, 343, 1313, 10.1056/NEJM200011023431806 Fischer, 2001, Primary immunodeficiency diseases: an experimental model for molecular medicine, Lancet, 357, 1863, 10.1016/S0140-6736(00)04959-X Sicherer, 1998, Primary immunodeficiency diseases in adults, Jama, 279, 58, 10.1001/jama.279.1.58 Hostofer, 2001, Disorders of host defense, 3 Lekstrom-Himes, 2000, Immunodeficiency diseases caused by defects in phagocytes, N Engl J Med, 343, 1703, 10.1056/NEJM200012073432307 Johnston, 2001, Clinical aspects of chronic granulomatous disease, Curr Opin Hematol, 8, 17, 10.1097/00062752-200101000-00004 Segal, 1998, Aspergillus nidulans infection in chronic granulomatous disease, Medicine, 77, 345, 10.1097/00005792-199809000-00004 Styrt, 1996, Risk of infection and protective strategies for the asplenic patient, Infect Dis Clin Pract, 5, 94, 10.1097/00019048-199602000-00002 1996, Guidelines for the prevention and treatment in patients with absent or dysfuncional spleen, B Med J, 312, 430, 10.1136/bmj.312.7028.430 Stephan, 1993, Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients, J Pediatr, 123, 564, 10.1016/S0022-3476(05)80951-5 Buckley, 1997, Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants, J Pediatr, 130, 378, 10.1016/S0022-3476(97)70199-9 Buckley, 1999, Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency, N Engl J Med, 340, 508, 10.1056/NEJM199902183400703 Winkelstein, 2000, Chronic granulomatous disease: report on a national registry of 368 patients, Medicine, 79, 155, 10.1097/00005792-200005000-00003 Marx, 2001, Gastrointestinal manifestations of primary immunodeficiencies, Curr Op Gastroenterol, 17, 551, 10.1097/00001574-200111000-00012 Eztioni, 2003, Immune deficiency and autoimmunity [en prensa], Autoimmun Rev Schurman, 2003, Autoimmunity in Wiskott- Aldrichl sindrome, Curr Opin Rheumatol, 15, 446, 10.1097/00002281-200307000-00012 Sallah, 2001, Future development of lymphoprolifetaive disordes in patients with autoimmune hemolytic anemia, Clin Cancer Res, 7, 791 Cunningham-rundles, 1999, Common variable immunodeficiency: clinical and immunological features of 248 patients, Clin Immunol, 92, 34, 10.1006/clim.1999.4725 Noroski, 1998, Screening for primary immunodeficiencies in the clinica laboratory, Clin Immunol Immunopathol, 86, 237, 10.1006/clin.1997.4469 Margolis, 1990, Trimethoprim- sulfametoxazole prophylaxis in the management of chronic granulomatous disease, J Infect Dis, 162, 723, 10.1093/infdis/162.3.723 Gallin, 2003, Itraconazole to prevent fungal infections in chronic granulomatous disease, N Engl J Med, 248, 2416, 10.1056/NEJMoa021931 2001, Vacunaciones en situaciones especiales. Inmunodeficiencias primarias. Manual de Vacunas en Pediatria, Edicion, 424